NEW YORK (

TheStreet

) --

CHANGE IN RATINGS

Activision Blizzard

(ATVI) - Get Report

rated new Outperform at Credit Suisse. $16 price target. Company can continue to expand around the globe.

Celgene

(CELG) - Get Report

downgraded at Piper from Overweight to Neutral, Piper Jaffray said. $86 price target. Company lacks near-term catalysts.

Check Point

(CHKP) - Get Report

downgraded at Needham from Buy to Hold, Needham said. Recent field checks suggest that sales could slow down in the coming quarters.

Cott Corp

(COT) - Get Report

rated new Buy at Citigroup. $10 price target. Strong EPS growth driven by a balance of factors.

Chevron

(CVX) - Get Report

rated new Hold at Dahlman. Two major LNG projects add risk to the thesis.

DR Horton

(DHI) - Get Report

downgraded at MKM from Buy to Neutral, MKM Partners said. Valuation call, as the sector has already made a big run.

Electronic Arts

(ERTS)

rated new Neutral at Credit Suisse. $16 price target. Company has struggled with its digital transition.

FedEx

(FDX) - Get Report

upgraded at Standpoint from Hold to Buy, Standpoint said. $130 price target. Company is cutting costs and annual earnings can approach $10 a share.

Genomic Health

(GHDX) - Get Report

rated new Neutral at Goldman. $36 price target. Company has limited earnings upside potential.

Host Hotels

(HST) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Expect slower industry RevPAR growth.

Johnson Controls

(JCI) - Get Report

downgraded at Wells from Outperform to Market Perform, Wells Fargo said. Management will struggle to turn the company around by 2013.

Lennar

(LEN) - Get Report

downgraded at MKM from Buy to Neutral, MKM Partners said. See limited upside to near-term earnings expectations.

Marriott

(MAR) - Get Report

downgraded at Goldman from Buy to Neutral, Goldman Sachs said. Stock has outperformed the market year-to-date.

MetroPCS Communications

(PCS)

downgraded at Oppenheimer to Underperform from Perform, Oppenheimer said. Wireless to eventually consolidate into three players.

Rite Aid

(RAD) - Get Report

rated new Buy at BTIG. $2.25 price target. Company is improving customer retention and margins.

Texas Instruments

(TXN) - Get Report

downgraded at Credit Suisse from Outperform to Neutral, Credit Suisse said. $26 price target. Company is leveraged to slower macro growth.

Exxon Mobil

(XOM) - Get Report

rated new Buy at Dahlman. $100 price target. Company will continue to buy back stock in the coming quarters.

Zynga

(ZNGA) - Get Report

rated new Underperform at Credit Suisse. $3 price target. Company is losing customers, even for new games.

STOCK COMMENTS / EPS CHANGES

Adtran

(ADTN) - Get Report

numbers lowered at Jefferies. Shares of ADTN now seen reaching $13.25, Jefferies said. Estimates also lowered on ugly Q3. Underperform rating.

Dean Foods

(DF) - Get Report

numbers cut at UBS. Shares of DF now seen reaching $15.50, UBS said. Estimates also lowered on heightened dairy input cost pressure. Neutral rating.

FedEx

(FDX) - Get Report

target raised at Citigroup to $108, Citigroup said. EBIT improvement target supports above consensus estimates. Buy rating.

IAC/InterActiveCorp

(IACI)

numbers raised at Oppenheimer. Shares of IACI now seen reaching $67, Oppenheimer said. Estimates also raised on numerous catalysts. Outperform rating.

Eli Lilly

(LLY) - Get Report

target boosted at BofA/Merrill to $57, according to Bank of America/Merrill Lynch said. Sola should ultimately reach the market for Alzheimer's. Buy rating.

LyondellBasell

(LYB) - Get Report

estimates raised at UBS through 2013, UBS said. Improved refining partially offsets weaker European OPO. Neutral rating and $49 price target.

Progressive

(PGR) - Get Report

estimates, target raised at KBW. Shares of PGR now seen reaching $21, according to Keefe, Bruyette & Woods. Estimates also increased, given higher realized premium growth. Market Perform rating.

Universal Health

(UHS) - Get Report

numbers raised at Credit Suisse. Shares of UHS now seen reaching $53, according to Credit Suisse. Estimates also increased, as the Ascend deal should add to earnings. Outperform rating.

Yum! Brands

(YUM) - Get Report

numbers raised at UBS. Shares of YUM now seen reaching $84, UBS said. Estimates also increased on higher unit growth in China. Buy rating.

YUM! Brands numbers raised at Jefferies. Shares of YUM now seen reaching $70, Jefferies said. Estimates also raised on solid EPS beat. Hold rating.

>To submit a news tip, email:

tips@thestreet.com

.

READERS ALSO LIKE:

>>This Housing Recovery Is Real

>>Smart Money Is Sticking With Growth Stocks

Follow

TheStreet

on

Twitter

and become a fan on

Facebook.

This article was written by a staff member of TheStreet.